OTX-14-002: Device Exposure Registry

Withdrawn

• Conditions: Endophthalmitis

• Registration Number: NCT02309736
• Lead Sponsor: Ocular Therapeutix, Inc.

Brief Summary

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2014-12-03
• Study First Submitted QC: 2014-12-03
• Study First Posted: 2014-12-05
• Status Verified: 2020-02
• Last Update Submitted: 2020-02-03
• Last Update Posted: 2020-02-05
• Primary Completion: 2020-04

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence of endophthalmitis	Day 30